Regulatorische Updates
27. Aug. 2026•1 Min. Lesezeit
FDA Approves Multiple Submissions for SCANDONEST L Injection (Discontinued)
The FDA record shows SCANDONEST L injectable, containing levonordefrin and mepivacaine, has a discontinued marketing status and a history of approved labeling and manufacturing submissions dating from 1984 to 2018.
Regulatorische Updates
25. Aug. 2026•1 Min. Lesezeit
FDA ANDA 086095: Watson Labs Chlorpheniramine Injection Discontinued
The FDA lists ANDA 086095 for Watson Labs' chlorpheniramine maleate injectable (100 mg/mL). The product is marked discontinued.
1
Regulatorische Updates
23. Aug. 2026•1 Min. Lesezeit
Orbit Pharma Recalls Cyclizine Lactate Injection Batch Over GMP Deficiencies
Orbit Pharma Limited is recalling a batch of Cyclizine Lactate 50 mg/ml injection solution due to GMP deficiencies at the manufacturing site.
1